Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group

Işın AKYAR, (Acıbadem Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye)
Özlem AYDIN, (Acıbadem Üniversitesi, Tıp Fakültesi, Patoloji Anabilim Dalı, İstanbul, Türkiye)
Mustafa Cengiz YAKICIER, (Acıbadem Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye)
Zühtü Tanıl KOCAGÖZ, (Acıbadem Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye)
Ümit İNCE, (Acıbadem Üniversitesi, Tıp Fakültesi, Patoloji Anabilim Dalı, İstanbul, Türkiye)
İbrahim ÜNSAL (Acıbadem Üniversitesi, Tıp Fakültesi, Biyokimya Anabilim Dalı, İstanbul, Türkiye)
Turkish Journal of Medical Sciences
1 0
Yıl: 2013 Cilt: 43 Sayı: 6 Sayfa Aralığı: 963 - 970 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group

Öz:
Aim: To detect the prevalence and type distribution of human papillomavirus (HPV) in different cytological diagnostic categories. Materials and methods: Between 2007 and 2010, a total of 1014 liquid-based thin preparations of cervical smears were selected and classified according to cytology results. HPV DNA polymerase chain reaction (PCR) was also performed using these samples. HPV DNA-positive samples were genotyped by DNA sequencing. Results: Of those enrolled in the study, 45.3% were negative cytologically, 36.4% had atypical squamous cells of undetermined significance, 0.3% had atypical squamous cells preventing the exclusion of a high-grade squamous intraepithelial lesion, 16.8% showed a low-grade squamous intraepithelial lesion, and 1.3% had an high-grade squamous intraepithelial lesion. Conclusion: PCR assays showed HPV positivity in 63.0% of cytologically negative and 90.8% of cytologically positive samples. The most common types of HPV detected were 16, 6, 18, 31, 66, 56, 53, 81, 45, and 62. Of HPV DNA-positive samples, 47.7% were high, 4.7% were intermediate, and 17.9% were low risk. The high-risk types of HPV detected were 16, 18, 31, 56, 53, 45, 62, 58, 59, 67, 51, 35, 73, 52, 33, 39, 68, and 82.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Kiki I, Gündoğdu M, Polat F, Gündoğdu C. Detection of human papillomavirus infection in esophageal carcinomas by the histopathological method and polymerase chain reaction technique. Turk J Med Sci 2002; 32: 223–230.
  • 2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19.
  • 3. World Health Organization. Bulletin of the World Health Organization (BLT) 84: 145–150. 2006. Available at http://www. who.int/bulletin/volumes/84/2.
  • 4. Burkhart CG, Burkhart CN. If papillomavirus found universally in epidermal tissues, what does that mean if a PCR pap test is positive? Open Dermatol J 2009; 3: 52–53.
  • 5. Turkish Cervical Cancer and Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009; 106: 206–209.
  • 6. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 2008; 46: 109–117.
  • 7. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R et al. Management of women who test positive for high- risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871–1876.
  • 8. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD et al. A comparison of single and combined visual, cytologic; and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemol Biomarkers Prev 2003; 12: 815–823.
  • 9. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46–52.
  • 10. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095–1101.
  • 11. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. 1st ed. Washington DC, USA: ASM Press; 2007.
  • 12. Centers for Disease Control and Prevention. Division of STD Prevention. Prevention of genital HPV infection and sequelae: report of an external consultants’ meeting. Atlanta, GA, USA: CDC; updated 4 2012. 1999. Available at http://www.cdc.gov/ fmo/topic/budget%20information/appropriations_budget_ form_pdf/fy2012_cdc_cj_final.pdf.
  • 13. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM; ALTS Group. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195: 1582–1589.
  • 14. World Health Organization International Agency for Research on Cancer. Monographs on the Evaluation of Carcinogenic Risks to Humans: A Review of Human Carcinogens. Lyon, France: International Agency for Research on Cancer Working Group; 2011.
  • 15. Norkin LC. Virology: Molecular Biology and Pathogenesis. Washington DC, USA: ASM Press, 2010.
  • 16. Parkin DM, Bray F. The burden of HPV related cancers. Vaccine 2006; 24: S11–S25.
  • 17. Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005; 97: 1066–1071.
  • 18. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072–1079.
  • 19. Berkhof J, Bulkmans NW, Bleeker MC, Bulk S, Snijders PJ, Voorhorst FJ, Meijer CJ. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 2006; 15: 1268– 1273.
  • 20. Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, van Kemenade FJ, Snijders PJ, Meijer CJ. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in the Netherlands. Br J Cancer 2006; 94: 171–175.
  • 21. Wheeler CM, Hunt WC, Schiffman M, Castle PE. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006; 194: 1291–1299.
  • 22. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Hansson BG, Rylander E, Dillner J. HPV type-specific risks of highgrade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer 2007; 97: 129–132.
  • 23. Seçkin S, Aksoy F, Yıldırım M. Servikal smearlerde HPV infeksiyonu görülme insidansı. Ankara Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi 1996; 36: 101–103 (article in Turkish).
  • 24. Safi Z, Demirezen S, Beksaç MS. İnsan papilloma virusunun (IPV) polimeraz zincir reaksiyonu tekniği ile servikal ve vajinal akıntı örneklerinde saptanması. Klinik Bilimler & Doktor 2002; 8: 112–114 (article in Turkish).
  • 25. Tuncer ZS, Basaran M, Ustaçelebi S, Kuzey GM. High risk human papillomavirus (HPV) infection determined by hybrid capture II assay in a Turkish university hospital outpatient clinic. MN-Gorm 2006; 129–134 (article in Turkish).
  • 26. İnal MM, Köse S, Yıldırım Y, Özdemir Y, Töz E, Ertopçu K et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007; 17: 1266–1270.
  • 27. Koyuncu E. Taksim Eğitim ve Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Polikliniği’ne başvuran hastaların servikal sitolojilerin servikal kanser risk faktörlerine göre analizi–normal ve anormal sitolojik sonuçlarda yüksek onkojenik HPV prevalansı. PhD, Taksim Training and Research Hospital, Department of Microbiology, 2006.
  • 28. Bibbo M, Wilbur D. Cytologic Screening Programs in Comprehensive Cytopathology. Philadelphia, PA, USA: Saunders; 2008.
  • 29. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. Chicago, IL, USA: Springer; 2004.
  • 30. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 2004; 42: 3176–184.
  • 31. Şahiner F, Gümral R, Sener K, Yiğit N, Dede M, Yapar M, Kubar A. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and typespecific real-time PCR]. Mikrobiyol Bul 2012; 46: 624–636 (article in Turkish with English abstract).
  • 32. Hlaing T, Yip YC, Ngai KL, Vong HT, Wong SI, Ho WC, Batalha SL, Chan PK. Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao. J Med Virol 2010; 82: 1600–1605.
  • 33. Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, Jiang W, Xiao Q, Luan X, Qian X et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer 2012; 12:160.
  • 34. Martin P, Kilany L, Garcia D, Lopez-Garcia AM, Martin-Azana MJ, Abraira V, Bellas C. Human papillomavirus genotype distribution in Madrid and correlation with cytological data. Infect Dis 2011; 11: 316.
  • 35. Piana A, Sotgiu G, Castiglia P, Pischedda S, Cocuzza C, Capobianco G, Marras V, Dessole S, Muresu E. Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Public Health 2011; 11: 785.
  • 36. de Mendez MT, Bosch AL. Detection and genotyping of human papillomavirus DNA using polymerase chain reaction short PCR fragment 10-line probe assay in abnormal Papanicolaoustained cervicovaginal smears. Acta Cytol 2009; 23: 540–546.
  • 37. Altinbas SK, Tapisiz OL. Human papillomavirus, vaccines, and protection from cervical cancer. Saudi Med J 2012; 33: 1270– 1277.
APA AKYAR I, Aydın Ö, YAKICIER M, KOCAGÖZ Z, ince u, ÜNSAL İ (2013). Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. , 963 - 970.
Chicago AKYAR Işın,Aydın Özlem,YAKICIER Mustafa Cengiz,KOCAGÖZ Zühtü Tanıl,ince umit,ÜNSAL İbrahim Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. (2013): 963 - 970.
MLA AKYAR Işın,Aydın Özlem,YAKICIER Mustafa Cengiz,KOCAGÖZ Zühtü Tanıl,ince umit,ÜNSAL İbrahim Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. , 2013, ss.963 - 970.
AMA AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. . 2013; 963 - 970.
Vancouver AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. . 2013; 963 - 970.
IEEE AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ "Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group." , ss.963 - 970, 2013.
ISNAD AKYAR, Işın vd. "Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group". (2013), 963-970.
APA AKYAR I, Aydın Ö, YAKICIER M, KOCAGÖZ Z, ince u, ÜNSAL İ (2013). Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences, 43(6), 963 - 970.
Chicago AKYAR Işın,Aydın Özlem,YAKICIER Mustafa Cengiz,KOCAGÖZ Zühtü Tanıl,ince umit,ÜNSAL İbrahim Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences 43, no.6 (2013): 963 - 970.
MLA AKYAR Işın,Aydın Özlem,YAKICIER Mustafa Cengiz,KOCAGÖZ Zühtü Tanıl,ince umit,ÜNSAL İbrahim Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences, vol.43, no.6, 2013, ss.963 - 970.
AMA AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences. 2013; 43(6): 963 - 970.
Vancouver AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences. 2013; 43(6): 963 - 970.
IEEE AKYAR I,Aydın Ö,YAKICIER M,KOCAGÖZ Z,ince u,ÜNSAL İ "Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group." Turkish Journal of Medical Sciences, 43, ss.963 - 970, 2013.
ISNAD AKYAR, Işın vd. "Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group". Turkish Journal of Medical Sciences 43/6 (2013), 963-970.
Sayfa Oluşturulma Tarihi
23-04-2024 0:26

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları